Shareholder’s Council & Supervisory Board


Shareholder's Council

The Shareholders’ Council of Merz Pharma GmbH & Co. KGaA advises the Management Board; its duties include approving major projects, such as acquisitions and extraordinary transactions. The Shareholders’ Council has four members: two are appointed from the ranks of the Supervisory Board, and two others are members of the shareholder families.

Philip Burchard

Philip Burchard

Chairman of the Shareholders Council

  • Chief Executive Officer of Merz since 2012
  • Extensive experience in the pharmaceutical industry in Europe, Latin America and Asia
Dr. Christian Holzherr

Dr. Christian Holzherr

  • Chairman of the Supervisory Board, Member of the Shareholders’ Council and Chairman of the Tax and Audit Committee
  • Long track record of CEO and CFO positions in the pharmaceutical and medical device industry
Christian Baatz

Christian Baatz

  • Member of the shareholder families (fourth generation shareholder)
  • Master’s degree in Business Administration
Andreas Meyer

Andreas Meyer

  • Member of the shareholder families (fourth generation shareholder)
  • Business engineer

Supervisory Board

The Supervisory Board of Merz Pharma GmbH & Co. KGaA oversees the Management Board and is involved in decisions of major importance for the company. The following five members sit on the Supervisory Board:

  • Dr. Christian Holzherr, Chairman of the Supervisory Board Merz Pharma GmbH & Co. KGaA
  • Dr. Patricia Walker, Member of the Supervisory Board Merz Pharma GmbH & Co. KGaA
  • Christian Baatz, Member of the Supervisory Board Merz Pharma GmbH & Co. KGaA
  • Andreas Meyer, Member of the Supervisory Board Merz Pharma GmbH & Co. KGaA